Tumor Necrosis Factor-Alpha and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

    July 2009 in “ Cancer Research
    David Surguladze, Dhanvanthri S. Deevi, Nidia Claros, Erik Corcoran, Su Wang, Mary Jane Plym, Yan Wu, Jacqueline Doody, David J. Mauro, Larry Witte, Klaus J. Busam, Bronek Pytowski, Ulrich Rodeck, James R. Tonra
    TLDR Blocking certain proteins can reduce skin inflammation caused by cancer treatment.
    The study demonstrated that the monoclonal antibody ME1, targeting murine EGFR, induced neutrophil-rich hair follicle inflammation in mice, resembling the acneiform rash seen in cancer patients undergoing EGFR antibody therapy. This inflammation was associated with lipid-filled hair follicle distensions and enlarged sebaceous glands. The cytokine TNFα was up-regulated in the affected skin regions, and its involvement in the inflammatory process was confirmed by the reduction of skin inflammation through cotreatment with the TNFα inhibitor, etanercept. Additionally, the interleukin-1 antagonist Kineret was effective, suggesting that interleukin-1 also played a role. These findings provided a mechanistic basis for developing evidence-based treatments for EGFR antibody-induced skin rashes in cancer patients.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 78 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community SUBE3 for sale in the gray market?

      in Chat  5 upvotes 11 months ago
      SCUBE3 is available online but poses risks like tumor promotion and high costs. Users advise against using it due to health concerns and inefficacy as a standalone treatment.

      community Pyrilutamide 5 months results (before, after pics)

      in Progress Pictures  194 upvotes 2 years ago
      Tae147 has shared results of using pyrilutamide, a 5% concentration topical solution applied twice daily, in combination with minoxidil, to reduce scalp itchiness and hair shedding. Other users have shared their experiences with the treatment, as well as questions about its availability on the market.

    Similar Research

    6 / 1000+ results